Related Experiment Videos
[Morphine therapy: evaluation of patient information]
J Y Ranchere1, M H Delfosse, P Saltel
1Centre de lutte contre le cancer Léon-Bérard, Lyon, France.
Bulletin Du Cancer
|September 30, 1998
Summary
Cancer patients receiving morphine (M) reported better understanding and fewer worries compared to those not on M. Proper information significantly improves patient comfort with opioid therapy for pain management.
Area of Science:
- Oncology
- Palliative Care
- Pain Management
Background:
- Cancer pain significantly impacts patient quality of life.
- Effective pain management is crucial for cancer patients.
- Morphine is a common analgesic, but patient understanding and concerns exist.
Purpose of the Study:
- To assess patient understanding and concerns regarding morphine (M) use in cancer care.
- To compare information levels between patients receiving morphine and those not.
- To evaluate the impact of patient education on morphine acceptance.
Main Methods:
- A study was conducted in a Cancer Centre with 129 hospitalized patients.
- Patients were randomized and completed an open questionnaire.
- Data from 100 patients were analyzed, divided into morphine (M+) and no morphine (M-) groups.
Main Results:
- 97% of M+ patients believed morphine reduced pain, versus 85% of M- patients.
- Morphine was effective in 92% of M+ patients.
- M+ patients reported significantly less worry about addiction (8% vs 44%) and greater confidence in stopping treatment (97% vs 38%) compared to M- patients.
Conclusions:
- Patients receiving morphine in this study were generally well-informed and comfortable with their treatment.
- Cancer patients not receiving morphine often lack adequate information and harbor misconceptions.
- Effective patient education is key to successful and comfortable opioid therapy in cancer pain management.